The Company declared a Final Dividend @ 3.50 Rupees on each Equity Share.
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.6 pts less than Nifty Smallcap 250 and 4.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Poly Medicure's Board declared a final dividend of Rs. 3.50 per equity share (70% on face value of Rs. 5) for Financial Year 2025-26, subject to shareholder approval. The standalone net profit for FY 2025-26 was Rs. 33,598.49 lakhs, with consolidated revenue from operations at Rs. 53,451.14 lakhs, up from Rs. 44,082.82 lakhs in the previous year. The company also completed two international acquisitions during the year - Pendracare Group (Netherlands) and Medlstream/Citieffe Group (Switzerland). Earnings per share stood at Rs. 33.15 on standalone basis.
The dividend signals continued profitability and cash generation, providing regular returns to shareholders. However, the payout ratio is modest at around 10.5%, indicating the company is retaining most earnings for growth initiatives and acquisitions.